BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33305255)

  • 1. Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.
    Upadhyay UD; Schroeder R; Roberts SCM
    Contracept X; 2020; 2():100049. PubMed ID: 33305255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abortion service availability during the COVID-19 pandemic: Results from a national census of abortion facilities in the U.S.
    Kaller S; Muñoz MGI; Sharma S; Tayel S; Ahlbach C; Cook C; Upadhyay UD
    Contracept X; 2021; 3():100067. PubMed ID: 34308330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings.
    Godfrey EM; Fiastro AE; Jacob-Files EA; Coeytaux FM; Wells ES; Ruben MR; Sanan SS; Bennett IM
    Contraception; 2021 Jul; 104(1):82-91. PubMed ID: 33932401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes to medication abortion clinical practices in response to the COVID-19 pandemic.
    Tschann M; Ly ES; Hilliard S; Lange HLH
    Contraception; 2021 Jul; 104(1):77-81. PubMed ID: 33894247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote Delivery in Reproductive Health Care: Operation of Direct-to-Patient Telehealth Medication Abortion Services in Diverse Settings.
    Fiastro AE; Sanan S; Jacob-Files E; Wells E; Coeytaux F; Ruben MR; Bennett IM; Godfrey EM
    Ann Fam Med; 2022; 20(4):336-342. PubMed ID: 35831175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.
    Mello K; Smith MH; Hill BJ; Chakraborty P; Rivlin K; Bessett D; Norris AH; McGowan ML
    Contraception; 2021 Jul; 104(1):111-116. PubMed ID: 33930382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
    Upadhyay UD; Raymond EG; Koenig LR; Coplon L; Gold M; Kaneshiro B; Boraas CM; Winikoff B
    JAMA Intern Med; 2022 May; 182(5):482-491. PubMed ID: 35311911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Independent Abortion Providers: Findings from a Rapid-Response Survey.
    Roberts SCM; Schroeder R; Joffe C
    Perspect Sex Reprod Health; 2020 Dec; 52(4):217-225. PubMed ID: 33289197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing Structural Inequities, a Necessary Step Toward Ensuring Equitable Access to Telehealth for Medication Abortion Care During and Post COVID-19.
    Thompson TA; Northcraft D; Carrión F
    Front Glob Womens Health; 2022; 3():805767. PubMed ID: 35368993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of No-Test Telehealth and In-Person Medication Abortion.
    Ralph LJ; Baba CF; Biggs MA; McNicholas C; Hagstrom Miller A; Grossman D
    JAMA; 2024 Jun; ():. PubMed ID: 38913394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion.
    Karlin J; Sarnaik S; Holt K; Dehlendorf C; Joffe C; Steinauer J
    Contraception; 2021 Sep; 104(3):289-295. PubMed ID: 33932400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Carvajal D; Logan R; Dehlendorf C
    Contraception; 2022 May; 109():19-24. PubMed ID: 35131289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telehealth Uptake into Prenatal Care and Provider Attitudes during the COVID-19 Pandemic in New York City: A Quantitative and Qualitative Analysis.
    Madden N; Emeruwa UN; Friedman AM; Aubey JJ; Aziz A; Baptiste CD; Coletta JM; D'Alton ME; Fuchs KM; Goffman D; Gyamfi-Bannerman C; Kondragunta S; Krenitsky N; Miller RS; Nhan-Chang CL; Saint Jean AM; Shukla HP; Simpson LL; Spiegel ES; Yates HS; Zork N; Ona S
    Am J Perinatol; 2020 Aug; 37(10):1005-1014. PubMed ID: 32516816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pricing of medication abortion in the United States, 2021-2023.
    Upadhyay UD; Schroeder R; Kaller S; Stewart C; Berglas NF
    Perspect Sex Reprod Health; 2024 Jul; ():. PubMed ID: 38956948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
    Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences and Perceptions of Telehealth Visits in Diabetes Care During and After the COVID-19 Pandemic Among Adults With Type 2 Diabetes and Their Providers: Qualitative Study.
    Sun CA; Shenk Z; Renda S; Maruthur N; Zheng S; Perrin N; Levin S; Han HR
    JMIR Diabetes; 2023 Jul; 8():e44283. PubMed ID: 37463021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of U.S. state-level abortion restrictions with medication abortion service delivery innovations during the early COVID-19 pandemic.
    Janiak E; Belizaire C; Liu J; Fulcher IR
    Contraception; 2022 Sep; 113():26-29. PubMed ID: 35430237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Srinivasulu S; Yavari R; Brubaker L; Riker L; Prine L; Rubin SE
    Contraception; 2021 Jul; 104(1):92-97. PubMed ID: 33910031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.